A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia

Phase Ii ◽

Phase Ii Study ◽

Lymphocytic Leukemia ◽

Macrophage Colony ◽

Combination of granulocyte-macrophage colony-stimulating factor (GM-CSF) and erythropoietin (EPO) for the treatment of advanced non-responsive chronic lymphocytic leukemia

European Journal Of Haematology ◽

10.1111/j.1600-0609.1999.tb01135.x ◽

2009 ◽

Vol 63 (5) ◽

pp. 325-331 ◽

Cited By ~ 3

Author(s):

Filippo Russo ◽

Stefano Guadagni ◽

Gioacchino Mattera ◽

Giuseppe Esposito ◽

Giuseppe Abate

Keyword(s):

Lymphocytic Leukemia ◽

Gm Csf ◽

Macrophage Colony ◽

Multiple‐dose granulocyte‐macrophage–colony‐stimulating factor plus 23‐valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia

Cancer ◽

10.1002/cncr.23561 ◽

2008 ◽

Vol 113 (2) ◽

pp. 383-387 ◽

Cited By ~ 32

Author(s):

Amar Safdar ◽

Gilhen H. Rodriguez ◽

Adriana M. Rueda ◽

William G. Wierda ◽

Alessandra Ferrajoli ◽

...

Keyword(s):

Pneumococcal Vaccine ◽

Multiple Dose ◽

Lymphocytic Leukemia ◽

Macrophage Colony ◽

Polysaccharide Pneumococcal Vaccine ◽

Phase II study of granulocyte-macrophage colony stimulating factor (GM-CSF) plus thalidomide in patients (pts) with hormone naïve adenocarcinoma of the prostate

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4743 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4743-4743 ◽

Cited By ~ 1

Author(s):

J. Hernandez ◽

R. J. Amato

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gm Csf ◽

Adenocarcinoma Of The Prostate ◽

Macrophage Colony ◽

Phase II Study of Combination Thalidomide/Interleukin-2 Therapy Plus Granulocyte Macrophage-Colony Stimulating Factor in Patients With Metastatic Renal Cell Carcinoma

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31815e4505 ◽

2008 ◽

Vol 31 (3) ◽

pp. 237-243 ◽

Cited By ~ 15

Author(s):

Robert J. Amato ◽

Rahul Malya ◽

Anish Rawat

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Macrophage Colony ◽

“Primum non nocere”: the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2012.727420 ◽

2012 ◽

Vol 54 (3) ◽

pp. 441-442

Author(s):

Daphne R. Friedman

Keyword(s):

Lymphocytic Leukemia ◽

Macrophage Colony ◽

Phase II Study of Ketoconazole Plus Granulocyte-Macrophage Colony-Stimulating Factor for Prostate Cancer: Effect of Extent of Disease on Outcome

The Journal of Urology ◽

10.1016/j.juro.2007.08.011 ◽

2007 ◽

Vol 178 (6) ◽

pp. 2372-2377 ◽

Cited By ~ 14

Author(s):

Charles J. Ryan ◽

Vivian Weinberg ◽

Jonathan Rosenberg ◽

Lawrence Fong ◽

Amy Lin ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Macrophage Colony ◽

Stimulating Factor ◽

Extent Of Disease

Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte–Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2014.11.037 ◽

2015 ◽

Vol 26 (4) ◽

pp. 523-532.e2 ◽

Cited By ~ 36

Author(s):

Matias E. Valsecchi ◽

Mizue Terai ◽

David J. Eschelman ◽

Carin F. Gonsalves ◽

Inna Chervoneva ◽

...

Keyword(s):

Uveal Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Hepatic Metastases ◽

Randomized Phase Ii ◽

Macrophage Colony ◽

Double Blinded ◽

Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2013.819574 ◽

2013 ◽

Vol 55 (4) ◽

pp. 828-833 ◽

Cited By ~ 7

Author(s):

Paolo Strati ◽

Alessandra Ferrajoli ◽

Susan Lerner ◽

Susan O’Brien ◽

William Wierda ◽

...

Keyword(s):

Lymphocytic Leukemia ◽

Frontline Treatment ◽

Macrophage Colony ◽

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia

Cancer ◽

10.1002/cncr.11238 ◽

2003 ◽

Vol 97 (7) ◽

pp. 1711-1720 ◽

Cited By ~ 66

Author(s):

Apostolia M. Tsimberidou ◽

Hagop M. Kantarjian ◽

Jorge Cortes ◽

Deborah A. Thomas ◽

Stefan Faderl ◽

...

Keyword(s):

Lymphocytic Leukemia ◽

Liposomal Daunorubicin ◽

Gm Csf ◽

Richter Syndrome ◽

Macrophage Colony ◽

The Combination of Fludarabine, Cyclophosphamide, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphoma

Clinical Lymphoma ◽

10.3816/clm.2005.n.023 ◽

2005 ◽

Vol 6 (1) ◽

pp. 26-30 ◽

Cited By ~ 13

Author(s):

Ruta Rao ◽

Jamile M. Shammo ◽

Sari H. Enschede ◽

Carlene Porter ◽

Solomon S. Adler ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Lymphocytic Leukemia ◽

Hodgkin's Lymphoma ◽

Low Grade ◽

Non Hodgkin's Lymphoma ◽

Macrophage Colony ◽